<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03930121</url>
  </required_header>
  <id_info>
    <org_study_id>DC-Train-Aphasia</org_study_id>
    <nct_id>NCT03930121</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation to Enhance Training Effectiveness in Chronic Post-Stroke Aphasia</brief_title>
  <official_title>Transcranial Direct Current Stimulation to Enhance Training Effectiveness in Chronic Post-Stroke Aphasia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medicine Greifswald</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate whether intensive speech-language therapy (SLT)
      combined with anodal transcranial direct current stimulation (tDCS) leads to better
      communication performance than SLT combined with placebo stimulation (using sham-tDCS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intensive speech-language therapy (SLT) can promote recovery from chronic post-stroke
      aphasia, but effect sizes are moderate. This highlights the pressing need to explore adjunct
      strategies, such as transcranial direct current stimulation (tDCS), to enhance training
      effectiveness. Recently, the investigators provided evidence from a single-center randomized
      controlled trial (RCT) suggesting that anodal-tDCS of the left primary motor cortex (M1)
      improves naming and communication ability in chronic post-stroke aphasia, with
      medium-to-large effect sizes. However, prior to integration into clinical routine, a
      multi-center RCT with adequate power, duration, and outcomes relevant to everyday life is
      required, which is the goal of the present study. After trial completion, a workshop with
      relevant stakeholders will ensure transfer into best-practice guidelines.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 6, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two daily sessions of intensive speech-language therapy combined with transcranial direct current stimulation of the left primary motor cortex (M1)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in communication ability, as assessed by the Amsterdam Nijmegen Everyday Language Test</measure>
    <time_frame>Before the 3-week treatment period; immediately after the 3-week treatment period; 6- and 12-month follow ups</time_frame>
    <description>Amsterdam Nijmegen Everyday Language Test (A-scale; parallel versions used in counterbalanced order across participants); cf. Blomert L, Kean ML, Koster C, et al. Amsterdam-Nijmegen Everyday Language Test—Construction, Reliability and Validity. Aphasiology 1994; 8: 381-407.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in naming ability, as assessed based on personally relevant trained and untrained items, consistent with previous work (see description)</measure>
    <time_frame>Before the 3-week treatment period; immediately after the 3-week treatment period; 6- and 12-month follow ups</time_frame>
    <description>Personally relevant trained and untrained items, consistent with previous work; cf. Meinzer M, Darkow R, Lindenberg R, et al. Electrical stimulation of the motor cortex enhances treatment outcome in post-stroke aphasia. Brain 2016; 139: 1152-1163.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in (non-)verbal communication, as assessed by the Scenario Test</measure>
    <time_frame>Before the 3-week treatment period; 6-month follow-up</time_frame>
    <description>Scenario Test; cf. Nobis-Bosch R, Abel S, Krzok F, et al. Szenario Test—Testung verbaler und nonverbaler Aspekte aphasischer Kommunikation. ProLog, in preparation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in (non-)verbal communication, as assessed by the Communicative Effectiveness Index</measure>
    <time_frame>Before the 3-week treatment period; immediately after the 3-week treatment period; 6- and 12-month follow ups</time_frame>
    <description>Communicative Effectiveness Index; cf. Lomas J, Pickard L, Bester S, et al. The Communicative Effectiveness Index: development and psychometric evaluation of a functional communication measure for adult aphasia. J Speech Hear Disord 1989; 54: 113-124.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in attention and executive function, as assessed by the subscales Go/NoGo and Alertness from Test of Attentional Performance</measure>
    <time_frame>Before the 3-week treatment period; 6-month follow up</time_frame>
    <description>Subscales Go/NoGo and Alertness from Test of Attentional Performance; cf. Zimmermann P and Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (TAP). Herzogenrath: PSYTEST Verlag, 2002.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in non-verbal episodic memory, as assessed by the Figure Recognition Task from Benton Visual Retention Test</measure>
    <time_frame>Before the 3-week treatment period; 6-month follow up</time_frame>
    <description>Figure Recognition Task from Benton Visual Retention Test; cf. Benton Sivan A and Spreen O. Benton Test. Bern: Huber, 2009.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mood, as assessed by the German version of the 10-item Stroke Aphasic Depression Questionnaire</measure>
    <time_frame>Before the 3-week treatment period; immediately after the 3-week treatment period; 6- and 12-month follow ups</time_frame>
    <description>German version of the 10-item Stroke Aphasic Depression Questionnaire (SADQH-10); cf. Cobley CS, Thomas SA, Lincoln NB, et al. The assessment of low mood in stroke patients with aphasia: reliability and validity of the 10-item Hospital version of the Stroke Aphasic Depression Questionnaire (SADQH-10). Clin Rehabil 2012; 26: 372-381.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in health-related quality of life, as assessed by the Stroke and Aphasia Quality of Life Scale</measure>
    <time_frame>Before the 3-week treatment period; immediately after the 3-week treatment period; 6- and 12-month follow ups</time_frame>
    <description>Stroke and Aphasia Quality of Life Scale (SAQOL-39g); cf. Hilari K, Lamping DL, Smith SC, et al. Psychometric properties of the Stroke and Aphasia Quality of Life Scale (SAQOL-39) in a generic stroke population. Clin Rehabil 2009; 23: 544-557.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in health-related quality of life, as assessed by the EuroQol Health-Related Quality of Life Questionnaire</measure>
    <time_frame>Before the 3-week treatment period; immediately after the 3-week treatment period; 6- and 12-month follow ups</time_frame>
    <description>EuroQol Health-Related Quality of Life Questionnaire (EQ-5D-5L); cf. EuroQol G. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in direct and indirect costs during the 12-month study period, as assessed by the self-developed Patient Resource Consumption Questionnaire</measure>
    <time_frame>Before the 3-week treatment period; 6- and 12-month follow ups</time_frame>
    <description>Direct and indirect costs during the 12-month study period, as determined by the self-developed Patient Resource Consumption Questionnaire considering common standardized unit cost assumptions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in direct and indirect costs during the 12-month study period, as assessed by the Quality-Adjusted Life Years</measure>
    <time_frame>Before the 3-week treatment period; 6- and 12-month follow ups</time_frame>
    <description>Quality-Adjusted Life Years; cf. Whitehead SJ and Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull 2010; 96: 5-21.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in unpaid support provided by family members or friends, as assessed by the Burden of informal caregivers</measure>
    <time_frame>Before the 3-week treatment period; immediately after the 3-week treatment period; 6- and 12-month follow ups</time_frame>
    <description>Burden of informal caregivers; cf. van Exel NJ, Koopmanschap MA, van den Berg B, et al. Burden of informal caregiving for stroke patients. Identification of caregivers at risk of adverse health effects. Cerebrovasc Dis 2005; 19: 11-17.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Aphasia</condition>
  <condition>Post-stroke</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anodal transcranial direct current stimulation (tDCS) combined with speech-language therapy (SLT, including naming therapy and communicative-pragmatic therapy)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Placebo stimulation (using sham-tDCS) combined with SLT</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anodal transcranial direct current stimulation (tDCS) combined with speech-language therapy (SLT, including naming therapy and communicative-pragmatic therapy)</intervention_name>
    <description>Two daily sessions of intensive SLT combined with tDCS of the left primary motor cortex (M1)</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  left-hemisphere cortical or subcortical stroke with first-ever aphasic symptoms

          -  at least 6 months post-onset of stroke;

          -  aphasia, as determined by the Aachen Aphasia Test (AAT);

          -  13 moderate-to-severe word finding difficulties (maximum of 60% correct items on a
             computerized naming task at baseline);

          -  at least 1 correct reaction on the first part of the AAT subscale Token Test (ensuring
             basic comprehension skills);

          -  at least 1 point on the communicative task of the AAT subscale Spontaneous Speech
             (ensuring basic communication abilities);

          -  German as first language;

          -  intact left-hemisphere &quot;hand knob&quot; without right prefrontal lesions for placement of
             tDCS electrodes, as confirmed by magnetic resonance imaging or computer tomography
             scans.

        Exclusion Criteria:

          -  contraindications for tDCS (e.g., cardiac pacemaker, history of seizures, implanted
             metal inside the head);

          -  more than one clinically apparent stroke with aphasic symptoms;

          -  other severe neurological diseases (e.g., epilepsy, brain tumor, and subdural
             hematoma);

          -  history of severe alcohol or drug abuse;

          -  current severe depression;

          -  current psychosis or other relevant psychiatric condition;

          -  very severe apraxia of speech, as revealed by Hierarchical Word Lists;

          -  severe non-verbal cognitive deficits, as indicated by the Corsi Block-Tapping Task;

          -  severe uncontrolled medical problems;

          -  severely impaired vision or hearing that prevents patients from engaging in intensive
             SLT;

          -  changes in centrally active drugs within 2 weeks prior to study inclusion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Agnes Floeel, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medicine Greifswald</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Agnes Floeel, Prof.</last_name>
    <phone>+49 3834 86 6815</phone>
    <email>agnes.floeel@uni-greifswald.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Viola von Podewils, PhD</last_name>
    <phone>+49 3834 866759</phone>
    <email>viola.podewils@uni-greifswald.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aphasiestation RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beate Schumann</last_name>
      <phone>0241/8088556</phone>
      <email>bschumann@ukaachen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kliniken Schmieder Allensbach</name>
      <address>
        <city>Allensbach</city>
        <zip>78476</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Berthold Gröne</last_name>
      <phone>07533/8081456</phone>
      <email>b.groene@kliniken-schmieder.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schön Klinik Bad Aibling Harthausen</name>
      <address>
        <city>Bad Aibling</city>
        <zip>83209</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gudrun Klingenberg, Dr.</last_name>
      <phone>08061/9031581</phone>
      <email>gklingenberg@schoen-klinik.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wicker Klinik Bad Homburg</name>
      <address>
        <city>Bad Homburg</city>
        <zip>61348</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carla Berghoff, Dr.</last_name>
      <phone>06172/103160</phone>
      <email>berghoff@wickerklinik.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Moritz Kliniken Bad Klosterlausnitz</name>
      <address>
        <city>Bad Klosterlausnitz</city>
        <zip>07639</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anke Oertel</last_name>
      <phone>036601/ 49521</phone>
      <email>anke.oertel@moritz-klinik.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Median Klinik Bad Sülze</name>
      <address>
        <city>Bad Sülze</city>
        <zip>18334</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Fürst</last_name>
      <phone>038229/72530</phone>
      <email>daniela.fuerst@median-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ZAR Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10115</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anke Nicklas</last_name>
      <phone>030/285184555</phone>
      <email>nicklas@zar-berlin.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kliniken Schmieder Gailingen</name>
      <address>
        <city>Gailingen</city>
        <zip>78262</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Berthold Gröne</last_name>
      <phone>07533/8081456</phone>
      <email>b.groene@kliniken-schmieder.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University medicine Greifswald, department of Neurology</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnes Floeel, Prof</last_name>
      <phone>+49 (03834) 86 6815</phone>
      <email>agnes.floeel@uni-greifswald.de</email>
    </contact>
    <contact_backup>
      <last_name>Viola von Podewils, PhD</last_name>
      <phone>49 3834 866759</phone>
      <email>viola.podewils@uni-greifswald.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>BDH-Klinik Greifswald gGmbH</name>
      <address>
        <city>Greifswald</city>
        <zip>17491</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Platz, Prof. Dr.</last_name>
      <phone>03834/871201</phone>
      <email>Sekretariataed@bdh-klinikgreifswald.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Christophsbad Göppingen</name>
      <address>
        <city>Göppingen</city>
        <zip>73035</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelika Kartmann</last_name>
      <phone>07161/6019650</phone>
      <email>angelika.kartmann@christophsbad.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kliniken Schmieder Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Desirée Kämpfer</last_name>
      <phone>06221/6540390</phone>
      <email>d.kaempfer@kliniken-schmieder.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital zum Heiligen Geist Kempen</name>
      <address>
        <city>Kempen</city>
        <zip>47906</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Stute</last_name>
      <phone>02512/1421311</phone>
      <email>nathalie.stute@artemed.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tagesklinik MPI Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Regenbrecht</last_name>
      <phone>0341/9724980</phone>
      <email>frank.regenbrecht@medizin.uni-leipzig.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Logo Zentrum Lindlar</name>
      <address>
        <city>Lindlar</city>
        <zip>51789</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Keck</last_name>
      <phone>02266/9060</phone>
      <email>tina.keck@logozentrumlindlar.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>TheraVent aktiv Marbach</name>
      <address>
        <city>Marbach</city>
        <zip>71672</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katrin Baumann</last_name>
      <phone>07144/160960</phone>
      <email>katrin.baumann@theravent-aktiv.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Mauritius Therapieklinik</name>
      <address>
        <city>Meerbusch</city>
        <zip>40670</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefanie Brühl, PD Dr.</last_name>
      <phone>02159/6795216</phone>
      <email>stefanie.bruehl@stmtk.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aphasie-Zentrum Vechta gGmbH</name>
      <address>
        <city>Vechta</city>
        <zip>49377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Benhamza</last_name>
      <phone>04447/970134</phone>
    </contact>
    <contact_backup>
      <last_name>Kathrin Billo</last_name>
      <phone>04447/970134</phone>
      <email>kathrin.billo@aphasie-zentrum.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 16, 2019</study_first_submitted>
  <study_first_submitted_qc>April 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2019</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rehabilitation</keyword>
  <keyword>Intensive speech-language therapy</keyword>
  <keyword>Transcranial direct current stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Aphasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

